Gene Query: KPNA1

Dataset Description Geneva Score
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 31.5
Altering cancer transcriptomes using epigenomic inhibitors 23.15
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 23.15
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 19.7
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 19.6
Differential analysis of gene regulation at transcript resolution by RNA-Seq 18.54
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 18.54
RNAseq of HEK293 cells after Chtop knockdown 15.22
Co-transcriptional loading of RNA export factors shapes the human transcriptome 15.22
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 14.54
RNA sequencing of matched nephrectomy samples [RNA-seq] 14.54
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 14.51
The interplay between SOX4 and SMAD3 in the context of breast cancer 14.41
RNA-seq analysis of BAP1-depleted uveal melanoma cells 14.26
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 13.92
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 13.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 13.05
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 12.82
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 12.6
RNA expression analysis upon JMJD1C depletion 12.5
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 12.5
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 12.37
Identifying the molecular mode of action of itraconazole in colorectal cancer 12.25
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 11.81
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 11.66
Exploring ILF2 regulatory genes by next-generation sequencing 11.6
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.39
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 11.28
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 11.08
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 10.94
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 10.74
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 10.52
A role for ZNF598 in post-transcriptional gene regulation 10.44
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 10.33
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 10.26
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 10.17
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 10.17
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 10.03
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 9.95
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 9.92
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.89
3’ Uridylation Expands miRNA Target Repertoire 9.87
Transcriptomic analyssis following EHMT1/2 inhibition 9.79
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 9.74
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 9.74
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.71
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.6
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 9.52
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 9.4
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 9.32
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 9.15
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.05
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 9.04
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 9.03
Lineage specific differentiation is influenced by state of human pluripotency 9.03
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 8.98
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 8.86
Sensing self and nonself circular RNAs 8.85
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 8.84
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 8.84
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.83
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.83
RNA-Seq with and without RNase treatment in PCa cell lines 8.77
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 8.73
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 8.73
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 8.71
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 8.68
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.67
DIGIT regulates endoderm differentiation of human embryonic stem cells 8.67
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.62
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 8.52
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 8.48
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 8.48
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 8.34
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 8.26
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.24
Expression level comparison under dividing and quiescent states in human primary fibroblasts 8.21
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.21
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.18
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 8.12
Determination of tRNA aminoacylation levels by high throughput sequencing 8.12
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.11
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.11
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.11
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.1
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 8.09
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 8.07
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 8.07
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 8.05
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.02
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 7.92
RNAseq Analysis in glioblastoma cells treated with Mepazine 7.9
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 7.89
An RNA-centric dissection of host complexes controlling flavivirus infection 7.89
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 7.89
Dtx3L and Androgen Signaling in Prostate Cancer 7.79
FBXW7 modulates stress response by post-translational modification of HSF1 7.76
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.76
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.74
Examining serotonergic neuron differentiation from human iPSCs 7.7
SLIGRL-induced gene expression changes in NHEK cells 7.69
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 7.63
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 7.61
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 7.6
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.59
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.57
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.57
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 7.56
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.51
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 7.51
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 7.5
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 7.38
Transcriptomic analysis of the HOTAIR-regulated genes 7.36
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.34
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.34
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.34
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.33
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.3
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.29
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.17
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.09
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.05
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.05
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 7.05
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 7.05
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 7.05
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.0
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.97
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 6.96
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 6.96
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.95
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.9
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.88
Cajal bodies are linked to genome conformation 6.86
Cajal bodies are linked to genome conformation [RNA-Seq] 6.86
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 6.79
RNA transcriptome analysis during HSV-1 infection 6.78
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.77
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.76
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.76
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.76
High level DNA repair gene expression in human ES cells 6.75
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 6.71
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 6.66
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.65
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.59
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.58
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 6.58
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 6.55
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.54
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.5
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 6.48
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 6.46
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 6.46
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 6.41
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.4
MYCi975 regulates MYC target genes 6.39
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 6.38
Human Treg NaCl stimulation 6.37
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.36
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 6.33
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 6.33
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.33
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 6.31
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.3
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 6.23
U1 snRNP telescripting regulates size-function stratified human genome 6.21
Systematic discovery of endogenous human ribonucleoprotein complexes 6.21
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 6.2
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.18
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 6.17
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.15
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.14
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.14
Knockdown of ADNP in HCT116 colon cancer cells 6.12
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 6.1
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 6.09
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 6.09
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.0
AR-independent prostate cancer is sustained through FGF signaling 6.0
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.93
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.93
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 5.91
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.85
CDK12 mediated transcriptional regulation in U2OS cells 5.83
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 5.82
RNA-seq analysis of AML cells in response to ASLAN003 5.79
Human cell line and subcutaneous tumor 5.76
MYC dependent mRNA translation shapes gene expression and cell biology 5.73
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 5.73
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 5.73
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 5.72
Aneuploidy triggers an immune response 5.68
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 5.68
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.65
Profiling of escape kinetics of viruses subjected to RNAi 5.59
Global Mapping of Human RNA-RNA Interactions 5.55
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.52
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 5.51
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.51
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.5
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 5.5
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.49
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.46
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 5.42
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 5.42
BASP1 modifies the Tamoxifen response 5.4
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.39
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 5.38
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.38
MeRIP-seq for heat shock in B-cell lymphoma cells 5.36
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.33
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.31
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.29
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.29
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.24
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.23
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.23
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.21
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.21
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.19
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.06
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 5.04
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.03
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 5.02
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 5.01
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.96
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 4.94
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.93
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 4.92
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.91
The Genetic Landscape of Diamond-Blackfan Anemia 4.9
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.88
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 4.87
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.83
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.83
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 4.81
STRIPAK directs PP2A activity to promote oncogenic transformation 4.79
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.78
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 4.75
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 4.7
Regulation of protein translation during mitosis 4.68
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.65
SLAM-seq for K562 endogenous mRNA decay 4.62
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.62
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.62
Anti-inflammatory effect of indoleacrylic acid (IA) 4.6
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 4.59
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.59
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.58
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.58
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 4.58
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.56
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.55
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.54
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 4.52
Gene expression in GBM with Cav3.2 inhibition 4.46
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.44
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.44
Effect of PBK knockdown on C4-2 cell transcriptome 4.41
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.38
Noncoding regions are the main source of targetable tumor-specific antigens 4.37
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.34
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.26
Molecular Criteria for Defining the Naive Human Pluripotent State 4.25
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.25
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.16
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.16
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 4.16
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.14
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.06
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.06
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 3.97
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.94
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.94
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 3.92
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.92
ARID1A and ARID1B loss in HCT116 cells 3.9
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 3.87
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 3.87
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.85
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.82
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 3.82
MAIT cell RNA sequencing 3.77
Measure transcript integrity using RNA-seq data 3.75
AUF-1 affected genes in human skin cells 3.73
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 3.68
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 3.6
Transcriptional changes in lymphoma cells induced by LSD1 depletion 3.6
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.58
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.56
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.56
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.53
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.49
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.49
RNA-seq of RKO cells with cTAZ KO or putback 3.49
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 3.48
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.48
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.48
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 3.44
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.43
The transcriptome effect of overexpressing EZH2 in MCF7 3.38
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.37
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.36
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.29
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.26
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.25
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.24
IMP3 regulated gene expression in breast cancer cells 3.24
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 3.23
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 3.2
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.16
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.14
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.13
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.13
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.13
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.11
Gene expression profile in breast cancer cells 3.1
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.1
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.1
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.04
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.02
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 3.0
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 2.99
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 2.99
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.96
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.96
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.96
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.93
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.91
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.91
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.89
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.84
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.81
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.8
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.73
RNA Sequencing of Human iPS derived Cardiomyocytes 2.73
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.7
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.64
mRNA expression in human DAOY cells 2.62
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 2.6
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 2.6
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.58
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.56
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.55
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.49
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.48
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.47
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.45
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.44
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.4
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.39
Copper Regulation of HIF-1 Transcription Activity 2.37
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.37
RNA-Seq of PRMT1 overexpression ECA109 cells 2.36
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.34
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.33
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.33
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.32
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 2.31
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.3
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.29
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.27
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.26
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.26
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 2.24
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.15
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.15
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.13
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.07
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.05
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.01
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.01
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.0
SF3B1 Degron knockdown RNA-seq 1.95
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.95
Positively selected enhancer elements endow tumor cells with metastatic competence 1.91
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.85
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.82
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.8
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.8
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.79
The transcriptome and chromatin accessbility landscape of mammalian germline 1.78
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.77
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.73
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.7
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.69
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.68
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.68
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.67
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.66
RNA-seq of IL-4 stimulated human keratinocytes 1.62
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.58
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.53
An optimization system for isolating and sequencing of single human colon cancer cells 1.52
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.48
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.45
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.44
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.44
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.43
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.41
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.41
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.39
Modulation of nonsense-mediated decay by rapamycin 1.35
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.34
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.32
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 1.32
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.32
Transposon-based construction of strand-specific RNA-seq libraries 1.32
MicroRNA targetome analysis during HCMV infection 1.31
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.29
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.25
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.25
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.24
Myc activation coordinates gene transcription and protein translation responses 1.21
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.17
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.15
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.15
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.08
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.07
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.07
Human Treg IL-12 stimulation 1.05
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.04
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.04
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.02
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.01
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.95
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.93
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.91
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.89
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.85
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.84
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.84
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.84
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.81
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.81
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.81
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.79
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.78
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.78
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.78
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.77
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.77
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.77
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.75
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.75
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.74
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.73
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.73
Identification of a LIF-responsive replication-competent human β cell 0.72
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.71
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.71
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.63
Dilated cardiomyopathy vs Myocarditis 0.62
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.62
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.6
Modeling Human Cancer-induced Cachexia (Human) 0.59
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.56
Function and hormonal regulation of GATA3 in human first trimester placentation 0.54
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.51
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.43
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.43
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.39
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.39
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.38
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.38
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.38
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.37
Interphase condensins regulate ligand-depedent enhancer activation 0.37
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.34
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.34
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.32
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.31
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.31
HBEC-shp53-PCHD7 0.3
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.28
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.26
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.25
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.25
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.25
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.23
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.23
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.22
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.21
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.19
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.17
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.16
RNA seq analysis of human Fetal and adult derived Enterospheres 0.16
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.14
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.14
High-throughput sequencing of PROMPT-enriched samples. 0.13
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.13
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.12
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.12
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.03
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation